Literature DB >> 9106243

Association between the cannabinoid receptor gene (CNR1) and the P300 event-related potential.

J P Johnson1, D Muhleman, J MacMurray, R Gade, R Verde, M Ask, J Kelley, D E Comings.   

Abstract

In our prior study we observed a significant association between homozygosity for the > or = alleles of a microsatellite polymorphism of cannabinoid receptor genes (CNR1) and drug dependence. Decreased amplitude of the P300 wave of evoked related potentials (ERP) has long been shown to be associated with alcohol and drug dependence. The P300 wave reflects attentional resource allocation and active working memory. Since marijuana intoxication has a potent blocking effect on short-term memory we examined the association between the CNR1 alleles and the P300 wave amplitude at three electrodes in 35 alcohol and drug addicts, by MANOVA. There was a significant decrease in amplitude of the P300 wave for all three electrodes (P = 0.028) that was most marked for the frontal lobes (P = 0.008) in subjects homozygous for the CNR1 > or = 5 repeat alleles. Multivariate regression analysis indicated the CNR1 gene contributed to 20% of the variance of the frontal lobe P300 wave amplitude.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9106243     DOI: 10.1038/sj.mp.4000246

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  14 in total

1.  Cannabinoid receptor 1 gene polymorphisms and marijuana misuse interactions on white matter and cognitive deficits in schizophrenia.

Authors:  Beng-Choon Ho; Thomas H Wassink; Steven Ziebell; Nancy C Andreasen
Journal:  Schizophr Res       Date:  2011-03-21       Impact factor: 4.939

Review 2.  Endocannabinoid influence in drug reinforcement, dependence and addiction-related behaviors.

Authors:  Antonia Serrano; Loren H Parsons
Journal:  Pharmacol Ther       Date:  2011-07-18       Impact factor: 12.310

3.  Longitudinal predictors of cannabis use and dependence in offspring from families at ultra high risk for alcohol dependence and in control families.

Authors:  Shirley Y Hill; Bobby L Jones; Stuart R Steinhauer; Nicholas Zezza; Scott Stiffler
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2016-01-12       Impact factor: 3.568

4.  Cannabis receptor haplotype associated with fewer cannabis dependence symptoms in adolescents.

Authors:  Christian J Hopfer; Susan E Young; Shaun Purcell; Thomas J Crowley; Michael C Stallings; Robin P Corley; Soo Hyun Rhee; Andrew Smolen; Ken Krauter; John K Hewitt; Marissa A Ehringer
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2006-12-05       Impact factor: 3.568

5.  Developmental Endophenotypes: Indexing Genetic Risk for Substance Abuse with the P300 Brain Event-Related Potential.

Authors:  William G Iacono; Stephen M Malone
Journal:  Child Dev Perspect       Date:  2011-12-01

Review 6.  Cannabis and cognitive dysfunction: parallels with endophenotypes of schizophrenia?

Authors:  Nadia Solowij; Patricia T Michie
Journal:  J Psychiatry Neurosci       Date:  2007-01       Impact factor: 6.186

7.  (AAT)n repeat in the cannabinoid receptor gene, CNR1: association with schizophrenia in a Spanish population.

Authors:  Isabel Martínez-Gras; Janet Hoenicka; Guillermo Ponce; Roberto Rodríguez-Jiménez; Miguel Angel Jiménez-Arriero; Elena Pérez-Hernandez; Israel Ampuero; Jose Antonio Ramos-Atance; Tomas Palomo; Gabriel Rubio
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2006-06-20       Impact factor: 5.270

8.  Heritability and molecular-genetic basis of the P3 event-related brain potential: a genome-wide association study.

Authors:  Stephen M Malone; Uma Vaidyanathan; Saonli Basu; Michael B Miller; Matt McGue; William G Iacono
Journal:  Psychophysiology       Date:  2014-12       Impact factor: 4.016

Review 9.  A review of the interactions between alcohol and the endocannabinoid system: implications for alcohol dependence and future directions for research.

Authors:  Matthew J Pava; John J Woodward
Journal:  Alcohol       Date:  2012-03-27       Impact factor: 2.405

10.  Plasma growth hormones, P300 event-related potential and test of variables of attention (TOVA) are important neuroendocrinological predictors of early cognitive decline in a clinical setting: evidence supported by structural equation modeling (SEM) parameter estimates.

Authors:  Eric R Braverman; Thomas J H Chen; Thomas J Prihoda; William Sonntag; Brian Meshkin; B William Downs; Julie F Mengucci; Seth H Blum; Alison Notaro; Vanessa Arcuri; Michael Varshavskiy; Kenneth Blum
Journal:  Age (Dordr)       Date:  2007-05-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.